Middle East & Africa Human Microbiome Market

Middle East & Africa Human Microbiome Market Outlook

Government initiatives and support programs significantly impact the human microbiome market growth. Governments frequently give large sums of money and grants for studies on the human microbiome. This financial assistance speeds up the development of novel treatments, devices, and diagnostics. Funding supports the innovation and commercialization of products by startups and small-to-medium-sized enterprises (SMEs) in the human microbiome sector. For instance, the project launched by NIH can transform understanding of human health and prevent, diagnose, and treat various conditions. Part of the NIH’s Roadmap for Medical Research, the Human Microbiome Project will award US$ 115 million to researchers over the next five years. Regulating frameworks tailored to human microbiome-based products may be established or improved by governments, which would shorten the time and expense involved in introducing novel treatments to the market. Well-defined regulations guarantee the safety and efficacy of products, thereby increasing consumer trust and market uptake.

Microbiome-based therapeutics is a booming field. The interest in microbiome-based therapies has increased due to the recent approval of Vowst, a medication from Seres Therapeutics, to treat C. difficile infections.

Middle East & Africa Human Microbiome Market Country Insights

Based on country, the Middle East & Africa human microbiome market comprises South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2023.

An increasing number of research studies in South Africa is fueling the growth of the microbiome human market. According to the study, "Association Between Clinical and Environmental Factors and The Gut Microbiota Profiles in Young South African Children," published in PubMed Central in August 2021, a higher abundance of Prevotella in healthy individuals may have a protective effect against atopic dermatitis. Unlike in some child and adult studies in rural African communities, no depletion of Bacteroides was observed. The microbiota profiles in this study were more similar to those of children in the UAE, with an equal distribution of Firmicutes and Bacteroidota at the phylum level. This intermediate state between traditionally non-western and western microbiome microbial profiles has also been seen in South African adults. It has been linked in part to urbanization and changes in diet.

The growing prevalence of diabetes contributes to the human microbiome market growth in South Africa. Impaired or imbalanced gut microbial distribution (dysbiosis) may act as a risk factor for insulin resistance progression in Type 2 diabetes patients. According to the IDF Diabetes Atlas, ~4 million adults in South Africa had diabetes in 2021, and the number is expected to rise to nearly 7 million adults by 2045. The development of microbiome therapeutics products for treating diabetes is fueling the growth of the human microbiome market in South Africa.

Middle East & Africa Human Microbiome Market Company Profiles

Some of the key players operating in the market include MaaT Pharma; Ferring Holdings SA; AOBiome Therapeutics Inc; Finch Therapeutics Group Inc; Seres Therapeutics Inc; Merck & Co Inc; Rebiotix, Inc.; Yakult Honsha Co., Ltd.; IFF Nutrition & Biosciences; and Synthetic Biologics, Inc. among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Human Microbiome Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise